Small cell lung cancer

Disease1 paper

Humans1

Trial sponsors

GSK
Company2 trialsPhase 31,460 people
AbbVie
Company2 trialsPhase 31,192 people
PharmaMar
Company1 trialPhase 3613 people
BeiGene
Company1 trialPhase 3457 people
Merck & Co.
Company1 trialPhase 3453 people
AstraZeneca
Company2 trialsPhase 249 people
Celgene
Company1 trialPhase 299 people
AGC Biologics
Company1 trialPhase 228 people

Funding

National Cancer InstituteUS$597.5k1 grant since 2023

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
National Cancer InstituteFred Hutchinson Cancer CenterUS$597.5k2023–2028

Latest

4

JMIR Public Health and SurveillanceHumansYesterday

Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study

Preprints.orgHumansPreprint29 Sep

Whole-Genome Sequencing Reveals Somatic LINE-1 and Alu Retrotransposition Extending Beyond Lung Tumors into Adjacent Normal Tissue

Journal of Thoracic DiseaseReview11 Sep

Equity gaps in pulmonary nodule risk prediction for never-smokers: a real-world evidence-informed narrative review and policy analysis

Frontiers in MedicineHumans3 Sep

Development and application of a risk prediction nomogram for sarcopenia one year after surgery in early-stage non-small cell lung cancer patients